Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
Article in Viruses (February 2023)
HIV Vaccines and Cure
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 HIV Vaccine Efficacy Trials: RV144 and Beyond
-
Altmetric BadgeChapter 2 HIV T-Cell Vaccines
-
Altmetric BadgeChapter 3 HIV Broadly Neutralizing Antibodies: VRC01 and Beyond
-
Altmetric BadgeChapter 4 Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine
-
Altmetric BadgeChapter 5 Monkey Models and HIV Vaccine Research
-
Altmetric BadgeChapter 6 Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level
-
Altmetric BadgeChapter 7 HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
-
Altmetric BadgeChapter 8 The Molecular Biology of HIV Latency
-
Altmetric BadgeChapter 9 Cellular Determinants of HIV Persistence on Antiretroviral Therapy
-
Altmetric BadgeChapter 10 In Vitro and In Vivo Models of HIV Latency
-
Altmetric BadgeChapter 11 Measuring HIV Persistence on Antiretroviral Therapy
-
Altmetric BadgeChapter 12 Clinical Interventions in HIV Cure Research
Attention for Chapter 4:
Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine